Le Lézard

Communiqués de presse par sujet : Essais cliniques / Découvertes médicales

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

21 novembre 2017

09:00
A study published in Prostate Cancer and Prostatic Diseases demonstrated that physicians elected to perform fewer biopsies when phi testing was included in their overall, routine, clinical assessment. Phi testing is recommended for men presenting...

08:00
Audentes Therapeutics, Inc. , a biotechnology company focused on developing and commercializing gene therapy products for patients living with serious, life-threatening rare diseases, today announced the publication of "A Multicenter, Retrospective...

06:00
Sysmex Inostics, a subsidiary of Sysmex Corporation, a global leader in blood based circulating tumor DNA (ctDNA) analysis and molecular diagnostics for oncology is pleased to highlight an expert taskforce review of the incorporation of BEAMing...


20 novembre 2017

17:52
A small protein modification can trigger the aggressive migratory and invasive properties of prostate cancer cells, according to new research published on the cover of Oncotarget. The findings give greater insight into how cancers can move from one...

17:36
Quest Diagnostics , the world's leading provider of diagnostic information services, today provided an update on the impact of the Centers for Medicare and Medicaid Services (CMS) publication of finalized 2018 Medicare reimbursement rates for...

15:52
The Leukemia & Lymphoma Society® (LLS) continues to lead the charge to cancer cures through its aggressive research investment; the organization announced today it has committed an additional $46 million to fund the most innovative science at leading...

14:30
The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) and Pfizer Global Medical Grants today announced they have awarded funding to nine projects that use clinical care pathways to implement quality improvement (QI)...

10:36
Rethinking Stroke: Groundbreaking New Protocol in the Treatment of Stroke   A groundbreaking new study is helping hospitals and health systems around the world establish protocols that increase the time window of treatment for patients who have...

10:14
Riverside Radiology and Interventional Associates (RRIA), a leading provider of professional radiology services to hospitals and other healthcare providers, today announced the publication of an article co-authored by two RRIA physicians in The New...

09:07
ATCC, an established and trusted source of biological materials in the R&D community, today announced the release of an innovative, in vitro model system for a key mechanism of invasion and metastasis in lung cancer. This model is part of a larger...

09:00
BiondVax Pharmaceuticals Ltd. today announced the signing of the clinical trial agreement (CTA) for a Phase 2 clinical trial with the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH). The...

09:00
DNAtrix, a leader in the development of oncolytic virus immunotherapies for cancer, announced multiple studies detailing the mechanism and efficacy of DNX-2401 were presented at the 2017 Society for Neuro-Oncology (SNO) Annual Meeting, held in San...

08:32
Aujourd'hui, Takeda et Cognition Kit ont annoncé qu'elles présenteraient les résultats de MDD-5003, une étude pilote visant à examiner les données cognitives et d'évaluation de l'humeur provenant d'une montre Apple Watch chez des patients atteints...

08:05
Promentis Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing innovative therapies for neuropsychiatric disorders, today announced that it has commenced a Phase 1 single ascending dose study for its lead compound, SXC-2023....

08:00
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced the first patient has been enrolled in DESTINY-Gastric01, a pivotal phase 2 study in Japan and South Korea evaluating the safety and efficacy of DS-8201, an investigational...

07:00
NanoViricides, Inc. (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform (the "Company"), filed its quarterly report for its first quarter of financial year 2018 in a...

07:00
BioLineRx Ltd. , a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today that an abstract with partial results from the monotherapy portion of BL-8040's Phase 2a COMBAT study in pancreatic cancer was accepted...

03:00
Biohaven Pharmaceutical Holding Company Ltd. announced today that the Company has received agreement from the U.S. Food and Drug Administration (FDA) on the initial pediatric study plan (iPSP) for orally-dosed rimegepant. Rimegepant is a...


17 novembre 2017

16:15
A new real-world analysis of adults with type 2 diabetes and established cardiovascular disease (CVD) shows adult patients who initiated therapy with INVOKANA® (canagliflozin) or another sodium glucose cotransporter-2 inhibitor (SGLT2i) had a 43...

13:57
Takeda and Cognition Kit today announced that the companies will present results from MDD-5003, a pilot study to evaluate cognitive and mood assessment data using an Apple Watch wearable in patients with major depressive disorder (MDD) during the...

11:36
Americord Registry, the fastest growing cord blood bank based in New York City, has announced a significant advancement in stem cell research and clinical trials coming out of Duke University. The FDA has announced expanded access to Duke...


16 novembre 2017

16:01
18 months ago, Regen BioPharma Inc. commenced a program to identify small molecules that inhibit the NR2F6 nuclear receptor. The NR2F6 nuclear receptor has been identified as a potentially very important immune cell inhibitor (an immune checkpoint)...

15:48
Wize Pharma, Inc. (formerly known as OphthaliX, Inc.) (Wize) today announced the closing of its previously announced merger with Wize Pharma Ltd., a clinical-stage biopharmaceutical company (Wize Israel), focused on the treatment of ophthalmic...

14:50
Egalet Corporation (Egalet), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, today announced positive top-line results from a phase 3...

13:05
Guardant Health has added Bristol-Myers Squibb Company to the group of pharmaceutical companies it is working with to develop the GuardantOMNI assay, a 500-plus-gene liquid biopsy panel designed to accelerate clinical trials and the research of...

11:58
The U.S. Food and Drug Administration today approved Hemlibra (emicizumab-kxwh) to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A who have developed antibodies called Factor VIII (FVIII)...

10:13
The Lupus Foundation of America announced today it will provide $3.8 million in funding over the next five years to support the first-of-its-kind clinical trial in the United States to evaluate adult mesenchymal stem cells (MSC) as a treatment for...

10:00
Cognitive Computing, Artificial Intelligence (AI) and Machine Learning augments visual intelligence thereby addressing the clinical needs of care providers. Path to realize value is achieved by embedding intelligence in the clinical workflows to...

09:04
Seattle Children's has opened the first chimeric antigen receptor (CAR) T-cell immunotherapy trial in the U.S. for children and young adults with relapsed or refractory CD19- and CD22-positive acute lymphoblastic leukemia (ALL) that will...

09:00
New human clinical trial data presented at the Society for Neuroscience on Wednesday, November 15 shows supplementation with patented Neumentixtm Phenolic Complex K110-42 supports sustained attention and focus in young, healthy individuals....

09:00
Dr. Eric Lawitz, internationally recognized for his work in liver disease, published groundbreaking results from a Phase 3 study in patients with chronic hepatitis C infection and severe renal impairment.   The study was performed at the American...

08:31
RegeneRx Biopharmaceuticals, Inc. ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that Thymosin beta 4 (T?4), the active ingredient in RGN-259, a...

08:20
Mallinckrodt plc , a leading global specialty pharmaceutical company, announced results from two retrospective, claims-based analyses providing health economic insights on the use of OFIRMEV® (acetaminophen) injection ? intravenous (IV) acetaminophen...

07:00
AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain, reported the publication of a manuscript analyzing...

07:00
Medicenna Therapeutics Corp.  ("Medicenna" or "the Company") a clinical stage immuno-oncology company, announced that following the presentation of early results at the Congress for Neurosurgeons (Oct 9-11, 2017), additional clinical data from the...

07:00
Khondrion, a clinical-stage pharmaceutical company focusing on small molecule therapeutics for mitochondrial diseases, announces today that its CEO Prof. Dr. Jan Smeitink will present first results of Khondrion's KHENERGY study at the Dutch Life...

07:00
Les résultats de la phase 2 des essais cliniques avec le KH176 sur des patients adultes souffrant de maladies mitochondriales seront présentés à la conférence Dutch Life Sciences  Khondrion, société pharmaceutique se concentrant sur l'étape clinique...

07:00
BioLineRx Ltd. , a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today that it will host an investor breakfast meeting on Tuesday, December 5, 2017 at the Convene Conference Center near Grand Central in New...

04:00
Evelo Biosciences, a biotechnology company pioneering the therapeutic modality of monoclonal microbials, today announced a collaboration with Mayo Clinic to develop and commercialize monoclonal microbials for the treatment of inflammatory and...

03:24
Swedish Orphan Biovitrum AB (publ) (Sobitm) announces that the first patient has been randomised in the phase 3 study anaSTILLs, to evaluate efficacy and safety of anakinra in the treatment of Still's disease. The purpose of the study is to assess...

03:00
NEW HAVEN, Conn., Nov. 16, 2017 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. announced that it is completing enrollment today in the first of its two registrational Phase 3 clinical trials, Study BHV3000-301, to establish the safety...

02:00
DNAmito, Inc. (Palo Alto, CA) and Varian Medical Systems announced today a development and OEM agreement to integrate Prodecis into Varian's 360 Oncologytm care management software platform. Prodecis will enable 360 Oncology to deliver...


15 novembre 2017

21:36
Ascentage Pharma, a global clinical-stage biopharmaceutical company dedicated to developing apoptosis-targeted therapies, today announced that the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application for...

16:05
Recent Corporate and Clinical Developments: Appointed Peter Hoang as President and CEO Completed enrollment in ongoing Phase 2 dosing study of TPIV200 for treating triple-negative breast cancer (TNBC) Began enrolling patients into Phase 2...

16:05
QIAGEN N.V. today launched enhancements in its QIAGEN Clinical Insight (QCI) bioinformatics software automating the AMP/ASCO/CAP Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer, advancing precision...

15:03
Researchers from the University of Chicago, Dana-Farber Cancer Institute (DFCI), and Guardant Health, Inc. published new evidence of the genomic heterogeneity of advanced gastroesophageal cancers (GEA). The study suggests that patients with these...

12:00
Boys and young men in advanced stages of Duchenne muscular dystrophy experienced significant and sustained improvements in cardiac structure and function, as well as skeletal muscle function, following treatment with CAP-1002, the lead...

10:36
Noden Pharma DAC, a global specialty pharmaceutical company that is focused on acquiring prescription medicines across a broad range of therapeutic areas, announced today the approval by the U.S. Food and Drug Administration of Tekturna®(aliskiren)...

09:15
Seven years ago Cincinnati Children's scientists first used pluripotent stem cells to mimic natural human development and grow working human intestine in a lab. Today medical center doctors can bioengineer the gastrointestinal tissues of sick...

09:05
The sense of touch is often taken for granted. For someone without a limb or hand, losing that sense of touch can be devastating. While highly sophisticated prostheses with complex moving fingers and joints are available to mimic almost every hand...

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17